Thiago S Torres1, Leonardo S Bastos2, Luciana Kamel3, Daniel R B Bezerra3, Nilo M Fernandes3, Ronaldo I Moreira3, Alex Garner4, Valdilea G Veloso3, Beatriz Grinsztejn3, Raquel B De Boni3. 1. Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Av. Brasil 4365, 21040-360, Rio de Janeiro, Brazil. Electronic address: thiago.torres@ini.fiocruz.br. 2. Programa de Computação Cientifica, Fiocruz, Av. Brasil 4365, 21040-360, Rio de Janeiro, Brazil; Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, United Kingdom. 3. Instituto Nacional de Infectologia Evandro Chagas, Fiocruz, Av. Brasil 4365, 21040-360, Rio de Janeiro, Brazil. 4. Hornet INC, 3962 Ince Blvd, Culver City, CA 90232, United States.
Abstract
BACKGROUND: We evaluated the prevalence of sexualized drug use (Chemsex) and its association with moderate/high risk for substance use disorders and HIV sexual risk behavior among men who have sex with men (MSM). METHODS: We conducted a cross-sectional web-based survey among MSM from Rio de Janeiro (Brazil). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was used to screen people at moderate/high-risk for substance use disorders. Individuals found to be using substances in the prior three months were asked if they used before/during sex. Sexualized drug use was classified into: no sexualized drug use, sex using only alcohol (alcohol-sex), sex using only illicit drugs (drug-sex) and sex using alcohol and illicit drugs (alcohol-drug-sex). The questionnaire included questions about sociodemographic, HIV status/prevention and risk behavior. A multinomial regression model was performed to assess the factors associated with sexualized drug use. RESULTS: Overall, 1048 MSM completed the questionnaire; median age was 29 years. Prevalence of alcohol and illicit drug use in previous 3 months was 89 % and 49 %, respectively. Most MSM (64 %) reported sexualized drug use: 28 % alcohol-sex, 9 % drug-sex and 27 % alcohol-drug-sex. Median ASSIST scores were higher among those reporting sexualized drug use compared to no use. All HIV sexual risk behavior variables presented increasing prevalence across the outcome categories. In the adjusted multivariate model, having moderate/high-risk for substance use disorders were associated with sexualized drug use. CONCLUSIONS: MSM reporting sexualized drug use should receive brief intervention for substance use disorders and be evaluated for combination HIV prevention strategies including PrEP.
BACKGROUND: We evaluated the prevalence of sexualized drug use (Chemsex) and its association with moderate/high risk for substance use disorders and HIV sexual risk behavior among men who have sex with men (MSM). METHODS: We conducted a cross-sectional web-based survey among MSM from Rio de Janeiro (Brazil). The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) was used to screen people at moderate/high-risk for substance use disorders. Individuals found to be using substances in the prior three months were asked if they used before/during sex. Sexualized drug use was classified into: no sexualized drug use, sex using only alcohol (alcohol-sex), sex using only illicit drugs (drug-sex) and sex using alcohol and illicit drugs (alcohol-drug-sex). The questionnaire included questions about sociodemographic, HIV status/prevention and risk behavior. A multinomial regression model was performed to assess the factors associated with sexualized drug use. RESULTS: Overall, 1048 MSM completed the questionnaire; median age was 29 years. Prevalence of alcohol and illicit drug use in previous 3 months was 89 % and 49 %, respectively. Most MSM (64 %) reported sexualized drug use: 28 % alcohol-sex, 9 % drug-sex and 27 % alcohol-drug-sex. Median ASSIST scores were higher among those reporting sexualized drug use compared to no use. All HIV sexual risk behavior variables presented increasing prevalence across the outcome categories. In the adjusted multivariate model, having moderate/high-risk for substance use disorders were associated with sexualized drug use. CONCLUSIONS: MSM reporting sexualized drug use should receive brief intervention for substance use disorders and be evaluated for combination HIV prevention strategies including PrEP.
Authors: Liza Coyer; Anders Boyd; Udi Davidovich; Ward P H van Bilsen; Maria Prins; Amy Matser Journal: Addiction Date: 2021-09-22 Impact factor: 7.256
Authors: Paula M Luz; Thiago S Torres; Celline C Almeida-Brasil; Luana M S Marins; Valdilea G Veloso; Beatriz Grinsztejn; Joseph Cox; Erica E M Moodie Journal: AIDS Behav Date: 2021-03
Authors: Thiago S Torres; Paula M Luz; Luana M S Marins; Daniel R B Bezerra; Celline C Almeida-Brasil; Valdilea G Veloso; Beatriz Grinsztejn; Daphna Harel; Brett D Thombs Journal: Health Qual Life Outcomes Date: 2021-04-09 Impact factor: 3.186
Authors: Emilia M Jalil; Thiago S Torres; Claudia C de A Pereira; Alessandro Farias; Jose D U Brito; Marcus Lacerda; Daila A R da Silva; Nickols Wallys; Gabriela Ribeiro; Joyce Gomes; Thiffany Odara; Ludymilla Santiago; Sophie Nouveau; Marcos Benedetti; Cristina Pimenta; Brenda Hoagland; Beatriz Grinsztejn; Valdilea G Veloso Journal: Int J Environ Res Public Health Date: 2022-02-02 Impact factor: 3.390
Authors: Typhanye V Dyer; Rodman E Turpin; David J Hawthorne; Vardhmaan Jain; Sonica Sayam; Mona Mittal Journal: Int J Environ Res Public Health Date: 2022-04-05 Impact factor: 3.390
Authors: Daniel Íncera-Fernández; Manuel Gámez-Guadix; Santiago Moreno-Guillén Journal: Int J Environ Res Public Health Date: 2021-12-17 Impact factor: 3.390